Prevalence of transmitted resistance to common HIV drugs remains stable

prevalence of transmitted resistance to common hiv drugs remains stable

Sumary of Prevalence of transmitted resistance to common HIV drugs remains stable:

  • July 20, 2021 2 min read Source/Disclosures Published by: Disclosures: McClung reports no relevant financial disclosures.
  • Back to Healio The prevalence of transmitted resistance to common HIV drugs in the United States remained stable between 2014 and 2018, according to a study published recently in Clinical Infectious Diseases.
  • This includes nucleotide sequence data from drug resistance testing,” R.
  • The prevalence of transmitted resistance to coming HIV drugs has remained stable in the United States.
  • Source: Shutterstock “These data provide valuable insight into population-level drug resistance patterns and can inform clinical guidelines for the management of HIV and PrEP,” McClung said.
  • McClung explained that the study provided an updated look at transmitted drug resistance for non-nucleoside reverse transcriptase inhibitors, nucleoside reverse transcriptase inhibitors, and protease inhibitors.
  • In a first, it also included the prevalence of transmitted resistance to integrase strand transfer inhibitors (INSTIs) from a large sample.
  • “Standard genotypic drug resistance testing is recommended at entry into care for everyone with HIV in the U.S. to assist with selection of an initial ART regimen.

Want to know more click here go to source.

From -

Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close